Background: Due to the defficiency of sex hormone estrogen after the menopause, the quality of woman's life dramatically decreases. Atrophic vaginitis in particular is a frequent cause of problems in these women's sex life. Methods: The gynecologist can detect the problems related to atrophic vaginitis using directed medi- cal history; clinical picture is also easily recognized. Atrophic vaginits is treated with locally applied hormone preparations, 17 beta Estradiol in the form of vaginal tablets having been proven as the safest providing the highest compliance. Safety, efficinecy and good compliance of 17 beta Estradiol vaginal tablets in the treatment of atrophic vaginitis was also confirmed by Slovene gyencologists in an observational...
Objective: The CLOSER (CLarifying Vaginal Atrophy’s Impact On SEx and Relationships) survey investig...
The objective: to evaluate the clinical effectiveness of treatment of atrophic vaginitis in menopaus...
Due to the increase in life expectancy, today, most women live in a state of estrogen deficiency for...
Unlike hot flushes and night sweats which resolve spontaneously in time, atrophic symptoms affecting...
The problem of atrophic vaginitis (AV) in postmenopause is widespread; it is considered a natural ag...
Vulvovaginal atrophy (VVA) is a silent epidemic that affects up to 50%-60% of postmenopausal women w...
The paper present overview of the etiology and diagnostic evaluation and treatment of atrophic vagin...
Mary Jane Minkin,1 Ricardo Maamari,2 Suzanne Reiter3 1Department of Gynecology and Reproductive Medi...
PURPOSE OF INVESTIGATION: To verify the effectiveness and safety of low-dose 17beta-estradiol vagina...
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical ...
Postmenopausal hot flushes and night sweats will affect the quality of life of 25-75% of women and a...
Management of breast cancer includes systematic therapies including chemotherapy and endocrine thera...
OBJECTIVE: To update and expand the previous position statement of The North American Menopause Soci...
Menopause and the climacteric period are associated with adverse risk factors for the development of...
ABSTR ACT: Vulvar and vaginal atrophy (VVA) is a chronic and progressive medical condition common in...
Objective: The CLOSER (CLarifying Vaginal Atrophy’s Impact On SEx and Relationships) survey investig...
The objective: to evaluate the clinical effectiveness of treatment of atrophic vaginitis in menopaus...
Due to the increase in life expectancy, today, most women live in a state of estrogen deficiency for...
Unlike hot flushes and night sweats which resolve spontaneously in time, atrophic symptoms affecting...
The problem of atrophic vaginitis (AV) in postmenopause is widespread; it is considered a natural ag...
Vulvovaginal atrophy (VVA) is a silent epidemic that affects up to 50%-60% of postmenopausal women w...
The paper present overview of the etiology and diagnostic evaluation and treatment of atrophic vagin...
Mary Jane Minkin,1 Ricardo Maamari,2 Suzanne Reiter3 1Department of Gynecology and Reproductive Medi...
PURPOSE OF INVESTIGATION: To verify the effectiveness and safety of low-dose 17beta-estradiol vagina...
SA Kingsberg¹, S Kellogg², M Krychman³1University Hospitals Case Medical ...
Postmenopausal hot flushes and night sweats will affect the quality of life of 25-75% of women and a...
Management of breast cancer includes systematic therapies including chemotherapy and endocrine thera...
OBJECTIVE: To update and expand the previous position statement of The North American Menopause Soci...
Menopause and the climacteric period are associated with adverse risk factors for the development of...
ABSTR ACT: Vulvar and vaginal atrophy (VVA) is a chronic and progressive medical condition common in...
Objective: The CLOSER (CLarifying Vaginal Atrophy’s Impact On SEx and Relationships) survey investig...
The objective: to evaluate the clinical effectiveness of treatment of atrophic vaginitis in menopaus...
Due to the increase in life expectancy, today, most women live in a state of estrogen deficiency for...